Dr. Stephen Salloway, MD
Claim this profileButler Hospital
Affiliated Hospitals
Butler Hospital
Memory And Aging Program, Butler Hospital
Clinical Trials Stephen Salloway, MD is currently running
Emtricitabine
for Alzheimer's Disease
This is a randomized, double-blind clinical trial of a daily oral dose of 200 mg emtricitabine vs. placebo in 35 participants with biomarker-confirmed MCI or mild to moderate dementia due to Alzheimer's disease. Study duration for each subject participating in the placebo-controlled research study will be approximately 12 months (up to a 3 months Screening Period, Baseline visit (1 month), 6 months of placebo or emtricitabine dosing, and 1 month follow-up). Participants will have up to 2 months to complete all procedures for the month 6 study visit.
Recruiting
0 awards
Phase 1
8 criteria
Biomarker Identification
for Alzheimer's Disease
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Recruiting
1 award
N/A
5 criteria
More about Stephen Salloway, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Stephen Salloway, MD has experience with
- BIIB080
- BIIB080-matching Placebo
- Emtricitabine
- Self-Guided Lifestyle Intervention
- Structured Lifestyle Intervention
- No Treatment
Breakdown of trials Stephen Salloway, MD has run
Alzheimer's Disease
Mild Cognitive Impairment
Cognitive Impairment
Alzheimer's disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Salloway, MD specialize in?
Stephen Salloway, MD focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Stephen Salloway, MD currently recruiting for clinical trials?
Yes, Stephen Salloway, MD is currently recruiting for 2 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Stephen Salloway, MD has studied deeply?
Yes, Stephen Salloway, MD has studied treatments such as BIIB080, BIIB080-matching placebo, Emtricitabine.
What is the best way to schedule an appointment with Stephen Salloway, MD?
Apply for one of the trials that Stephen Salloway, MD is conducting.
What is the office address of Stephen Salloway, MD?
The office of Stephen Salloway, MD is located at: Butler Hospital, Providence, Rhode Island 02906 United States. This is the address for their practice at the Butler Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.